Sotera Health (SHC) Projected to Post Quarterly Earnings on Tuesday

Sotera Health (NASDAQ:SHC) is expected to be issuing its Q1 2026 results before the market opens on Tuesday, May 5th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $270.7790 million for the quarter. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Parties are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Tuesday, May 5, 2026 at 9:00 AM ET.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.02. The firm had revenue of $303.44 million for the quarter, compared to analyst estimates of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.Sotera Health’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.21 earnings per share. On average, analysts expect Sotera Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Sotera Health Stock Down 0.0%

NASDAQ:SHC opened at $15.56 on Friday. The firm has a market capitalization of $4.44 billion, a price-to-earnings ratio of 57.61 and a beta of 1.82. Sotera Health has a 1-year low of $10.80 and a 1-year high of $19.85. The company has a current ratio of 2.46, a quick ratio of 2.24 and a debt-to-equity ratio of 3.66. The business’s fifty day moving average price is $15.04 and its 200 day moving average price is $16.49.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on SHC shares. Piper Sandler raised Sotera Health from a “neutral” rating to an “overweight” rating and upped their price target for the company from $17.00 to $24.00 in a research report on Friday, January 9th. Wall Street Zen lowered Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Zacks Research lowered Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Wells Fargo & Company lowered Sotera Health to an “overweight” rating in a research report on Thursday, January 8th. Finally, Barclays dropped their price target on Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Eight investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Sotera Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.14.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company’s stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the transaction, the director directly owned 12,735,301 shares of the company’s stock, valued at $194,468,046.27. This represents a 43.98% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 15.36% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. PNC Financial Services Group Inc. increased its position in Sotera Health by 10.8% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,204 shares of the company’s stock worth $127,000 after purchasing an additional 705 shares during the last quarter. Federated Hermes Inc. increased its position in Sotera Health by 6.0% in the 4th quarter. Federated Hermes Inc. now owns 16,676 shares of the company’s stock worth $294,000 after purchasing an additional 944 shares during the last quarter. First Citizens Bank & Trust Co. increased its position in Sotera Health by 1.5% in the 4th quarter. First Citizens Bank & Trust Co. now owns 66,266 shares of the company’s stock worth $1,169,000 after purchasing an additional 970 shares during the last quarter. Legal & General Group Plc increased its position in Sotera Health by 0.5% in the 3rd quarter. Legal & General Group Plc now owns 255,526 shares of the company’s stock worth $4,019,000 after purchasing an additional 1,252 shares during the last quarter. Finally, California State Teachers Retirement System increased its position in Sotera Health by 0.9% in the 3rd quarter. California State Teachers Retirement System now owns 145,318 shares of the company’s stock worth $2,286,000 after purchasing an additional 1,315 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.